These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [TBL] [Abstract][Full Text] [Related]
3. [Medicinal and chemical approaches to focused search of agents for treatment and therapy of Alzheimer disease]. Bachurin SO Vopr Med Khim; 2001; 47(2):155-97. PubMed ID: 11450439 [TBL] [Abstract][Full Text] [Related]
4. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models. Sohrabji F Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752 [TBL] [Abstract][Full Text] [Related]
5. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease. Xu H; Wang R; Zhang YW; Zhang X Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779 [TBL] [Abstract][Full Text] [Related]
7. More than a decade of estrogen neuroprotection. Simpkins JW; Singh M Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S131-6. PubMed ID: 18631989 [TBL] [Abstract][Full Text] [Related]
8. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815 [TBL] [Abstract][Full Text] [Related]
9. Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection. Webber KM; Bowen R; Casadesus G; Perry G; Atwood CS; Smith MA Acta Neurobiol Exp (Wars); 2004; 64(1):113-8. PubMed ID: 15190686 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of Alzheimer's disease]. López OL; Becker JT Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384 [TBL] [Abstract][Full Text] [Related]
11. [Neurotransmitters in Alzheimer's disease]. Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771 [TBL] [Abstract][Full Text] [Related]
13. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Holmquist L; Stuchbury G; Berbaum K; Muscat S; Young S; Hager K; Engel J; Münch G Pharmacol Ther; 2007 Jan; 113(1):154-64. PubMed ID: 16989905 [TBL] [Abstract][Full Text] [Related]
14. [Estrogen: regulation of amyloid-beta protein metabolism and attenuation of amyloid-beta protein neurotoxicity]. Zhang S; Yao T Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):197-201. PubMed ID: 14628462 [TBL] [Abstract][Full Text] [Related]
15. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease. Pákáski M; Kálmán J Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955 [TBL] [Abstract][Full Text] [Related]
16. Direct, complex effects of estrogens on basal forebrain cholinergic neurons. Bora SH; Liu Z; Kecojevic A; Merchenthaler I; Koliatsos VE Exp Neurol; 2005 Aug; 194(2):506-22. PubMed ID: 15893308 [TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Brinton RD Learn Mem; 2001; 8(3):121-33. PubMed ID: 11390632 [TBL] [Abstract][Full Text] [Related]
19. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology. van Groen T; Kadish I Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane. Sheldahl LC; Marriott LK; Bryant DM; Shapiro RA; Dorsa DM Minerva Endocrinol; 2007 Jun; 32(2):87-94. PubMed ID: 17557034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]